会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • SYSTEM AND METHOD FOR COLLISION-FREE CAD DESIGN OF PIPE AND TUBE PATHS
    • 管道和管道无冲突CAD设计的系统与方法
    • WO2009158466A1
    • 2009-12-30
    • PCT/US2009/048607
    • 2009-06-25
    • SIEMENS PRODUCT LIFECYCLE MANAGEMENT SOFTWARE INC.MILLER, Justin, H.
    • MILLER, Justin, H.
    • G06F17/50
    • G06F17/50G06F17/509G06F2217/08G06F2217/34
    • A system, method, and computer program product for automated creation of collision-free paths for pipes and tubes in a CAD system. A method includes receiving inputs, in a data processing system, defining at least a start point and destination point for a pipe in a CAD environment, and a diameter for the pipe. The method includes determining sample points between the start point and destination point. The method also includes building a graph including the sample points and the start point and the destination points as nodes and a plurality of edges connecting the nodes. The method also includes computing a path through the graph between the start point and the destination point. The method also includes, for each node in the path, testing each edge connected to the node to determine if there is a collision along the edge between a test object model and a background model geometry in the CAD environment, and removing from the graph any edge that has a collision. If there is no collision along an edge of the path, then designating the path as a successful path and displaying the successful path to a user by the data processing system.
    • 一种用于在CAD系统中自动创建管道和管道的无碰撞路径的系统,方法和计算机程序产品。 一种方法包括在数据处理系统中接收在CAD环境中至少定义管道的起始点和目的地点的输入以及管道的直径。 该方法包括确定起始点和目标点之间的采样点。 该方法还包括构建包括采样点和起始点和目的地点作为节点的图形以及连接节点的多个边缘。 该方法还包括计算通过起始点和目的地点之间的图形的路径。 该方法还包括,对于路径中的每个节点,测试连接到节点的每个边缘,以确定沿着CAD环境中的测试对象模型和背景模型几何之间的边缘是否存在碰撞,以及从图形中移除任何 边缘有碰撞。 如果路径边缘没有碰撞,则将路径指定为成功路径,并通过数据处理系统向用户显示成功的路径。
    • 9. 发明申请
    • PROSTATE SPECIFIC ANTIGENS, CONJUGATES THEREOF, METHODS FOR THEIR PREPARATION AND USES THEREOF.
    • 前列腺特异性抗原,与其结合,其制备方法及其用途。
    • WO2004060915A3
    • 2005-03-03
    • PCT/US0338453
    • 2003-12-03
    • SLOAN KETTERING INST CANCERDANISHEFSKY SAMUEL JDUDKIN VADIMMILLER JUSTIN
    • DANISHEFSKY SAMUEL JDUDKIN VADIMMILLER JUSTIN
    • A61K39/21C07K14/16C12N9/64C07K9/00G01N33/574
    • C07K14/005A61K38/00A61K39/12A61K39/21A61K2039/55577A61K2039/6018A61K2039/6081A61K2039/627C07K9/00C07K16/3069C12N9/6445C12N2740/16122C12N2740/16134C12Y304/21077
    • The present invention provides compounds having formula (I): wherein W , W , R , R , R , R and R are as defined herein; and additionally provides methods for the synthesis thereof, compositions thereof, and methods of use thereof in the treatment of cancer, methods for the prevention of recurrence of cancer, and methods for inducing antibodies in a subject, comprising administering to a subject in need thereof, an effective amount of any of the inventive compounds as disclosed herein, either in conjugated form or unconjugated and in combination with a suitable immunogenic carrier. In another aspect, the invention provides an antibody or antibody fragment which binds specifically to a normal or transformed PSA glycan or glycopeptide of the invention. In another aspect, the invention provides an immunoassay method for the quantitative determination of normal or transformed PSA in a biological sample. In another aspect, the invention provides an immunoassay kit for assessing the presence and/or amount of normal or transformed PSA in a sample. In another aspect, the invention provides a diagnostic kit for diagnosing an adenocarcinoma of the prostate in an individual suspected of suffering therefrom, or for differentiating between a benign pathology of the prostate and an adenocarcinoma of the prostate in an individual suspected of suffering therefrom.
    • 本发明提供具有式(I)的化合物:其中W 1,W 2,R 1,R 3,R 4,R 2A和R 2B如本文所定义 ; 并且另外提供其合成方法,其组合物及其在癌症治疗中的应用方法,用于预防癌症复发的方法,以及在受试者中诱导抗体的方法,包括向有需要的受试者施用, 有效量的本文公开的任何本发明化合物,其以缀合形式或未偶联并与合适的免疫原性载体组合。 另一方面,本发明提供了与本发明的正常或转化的PSA聚糖或糖肽特异性结合的抗体或抗体片段。 另一方面,本发明提供了用于定量测定生物样品中正常或转化的PSA的免疫测定方法。 在另一方面,本发明提供了用于评估样品中正常或转化的PSA的存在和/或量的免疫测定试剂盒。 另一方面,本发明提供了一种诊断试剂盒,用于诊断怀疑患有其的个体中的前列腺腺癌,或用于区分怀疑患有前列腺的前列腺的良性病理和前列腺腺癌。
    • 10. 发明申请
    • PROSTATE SPECIFIC ANTIGENS, CONJUGATES THEREOF, METHODS FOR THEIR PREPARATION AND USES THEREOF.
    • 前列腺特异性抗原,与其结合,其制备方法及其用途。
    • WO2004060915A2
    • 2004-07-22
    • PCT/US2003/038453
    • 2003-12-03
    • SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCHDANISHEFSKY, Samuel, J.DUDKIN, VadimMILLER, Justin
    • DANISHEFSKY, Samuel, J.DUDKIN, VadimMILLER, Justin
    • C07K14/47
    • C07K14/005A61K38/00A61K39/12A61K39/21A61K2039/55577A61K2039/6018A61K2039/6081A61K2039/627C07K9/00C07K16/3069C12N9/6445C12N2740/16122C12N2740/16134C12Y304/21077
    • The present invention provides compounds having formula (I): wherein W 1 , W 2 , R 1 , R 3 , R 4 , R 2A and R 2B are as defined herein; and additionally provides methods for the synthesis thereof, compositions thereof, and methods of use thereof in the treatment of cancer, methods for the prevention of recurrence of cancer, and methods for inducing antibodies in a subject, comprising administering to a subject in need thereof, an effective amount of any of the inventive compounds as disclosed herein, either in conjugated form or unconjugated and in combination with a suitable immunogenic carrier. In another aspect, the invention provides an antibody or antibody fragment which binds specifically to a normal or transformed PSA glycan or glycopeptide of the invention. In another aspect, the invention provides an immunoassay method for the quantitative determination of normal or transformed PSA in a biological sample. In another aspect, the invention provides an immunoassay kit for assessing the presence and/or amount of normal or transformed PSA in a sample. In another aspect, the invention provides a diagnostic kit for diagnosing an adenocarcinoma of the prostate in an individual suspected of suffering therefrom, or for differentiating between a benign pathology of the prostate and an adenocarcinoma of the prostate in an individual suspected of suffering therefrom.
    • 本发明提供具有式(I)的化合物:其中W 1,W 2,R 1,R 3,R 4,R 2A和R 2B如本文所定义 ; 并且另外提供其合成方法,其组合物及其在癌症治疗中的应用方法,用于预防癌症复发的方法,以及在受试者中诱导抗体的方法,包括向有需要的受试者施用, 有效量的本文公开的任何本发明化合物,其以缀合形式或未偶联并与合适的免疫原性载体组合。 另一方面,本发明提供了与本发明的正常或转化的PSA聚糖或糖肽特异性结合的抗体或抗体片段。 另一方面,本发明提供了用于定量测定生物样品中正常或转化的PSA的免疫测定方法。 另一方面,本发明提供了用于评估样品中正常或转化的PSA的存在和/或量的免疫测定试剂盒。 另一方面,本发明提供了一种诊断试剂盒,用于诊断怀疑患有其的个体中的前列腺腺癌,或用于区分怀疑患有前列腺的前列腺的良性病理学和前列腺腺癌之间的差异。